Are you finding yourself getting out of bed with stiff hips back and neck You may have Polymyalgia Rheumatica PMR Here’s all ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...

The treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...

"Giant cell arteritis is an inflammatory disease that, if left untreated, can lead to severe outcomes like blindness, stroke or aortic aneurysm,"2 said Prof. Dr. med. Wolfgang Schmidt, M.D., MACR, ...

Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. It can affect arteries, veins, and capillaries. This condition causes blood vessel walls to swell, which restricts ...

The long-term therapy and surveillance of patients with GCA is important. The side effects of long-term steroid therapy are protean and must be addressed. All patients need adequate calcium and ...

Dr. William Tap led the development of vimseltinib for tenosynovial giant cell tumor. The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult patients with symptomatic tenosynovial giant cell tumors (TGCT) who will not ...

Giant cell arteritis (GCA) encompasses a broader clinical ... A total of 93 patients received temporal artery biopsy (TAB), among which 53 (57%) had positive results; 18 out of 63 patients ...